Hologic stock holds near 52-week high as market values diagnostics growth

Hologic stock is trading close to its 52-week high as investors focus on the company’s role in diagnostics markets and a solid valuation backdrop ahead of the next earnings update.

Hologic stock (ISIN US4364401012) is quoted at 76.00 USD as of September 3, 2026, leaving the share just below its 52-week high of 76.07 USD according to market data compiled by MarketBeat.

Stock near high with solid valuation

According to a same-day price snapshot, Hologic stock trades at 76.00 USD while the 52-week range stretches from a low that is only slightly below to a high of 76.07 USD, so the current level sits within a fraction of the yearly peak.

The same overview cites a market capitalization reference from MarketBeat, underlining that at the current price level Hologic is valued firmly in the large mid-cap health care space, a point that matters for investors comparing diagnostics peers.

Diagnostics demand supports the story

Hologic’s positioning in diagnostic testing is indirectly reflected in sector studies such as a rhinovirus diagnostics market outlook that highlights a projected market size of 1.71 billion USD in 2026 and 2.33 billion USD by 2030.

For investors, such growth expectations in virology and respiratory diagnostics underline why shares of established players like Hologic can remain close to their 52-week highs while the broader market continues to re-rate health care names.

Representative product in diagnostics

Hologic is known for its portfolio in diagnostic testing, including molecular assays for respiratory pathogens and women’s health, which generate recurring revenue from laboratories and hospitals worldwide.

Stock price context for investors

With Hologic stock at 76.00 USD as of September 3, 2026, close to the 52-week high of 76.07 USD, the current valuation reflects strong confidence in the company’s diagnostics exposure even ahead of the next set of quarterly figures.

Hologic stock facts

• Company: Hologic Inc.
• ISIN: US4364401012
• Ticker: HOLX
• Trading venue: NASDAQ
• Price (as of September 3, 2026): 76.00 USD
• Market capitalization: Reference mid-cap health care level (as of September 3, 2026)
• Sector / Industry: Health Care / Diagnostics
• Index membership: S&P 500